Raphaël Rousseau
Corporate Officer/Principal chez DAY ONE BIOPHARMACEUTICALS, INC.
Profil
Raphaël Rousseau is a Strategic Advisor at Day One Biopharmaceuticals, Inc. He previously worked as a Senior Group Medical Director at Genentech, Inc. from 2012 to 2017 and as a Senior Medical Director at Roche Corp.
from 2010 to 2012.
He also served as the Chief Medical Officer & Executive Vice President at Gritstone bio, Inc. from 2017 to 2021.
Prior to his industry experience, he worked as a Professor at Université Claude Bernard Lyon 1.
Dr. Rousseau holds doctorate degrees from Université Paris Diderot-Paris 7 and Université de Paris 5 René Descartes.
Postes actifs de Raphaël Rousseau
| Sociétés | Poste | Début |
|---|---|---|
| DAY ONE BIOPHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/02/2024 |
Anciens postes connus de Raphaël Rousseau
| Sociétés | Poste | Fin |
|---|---|---|
| GRITSTONE BIO, INC. | Chief Tech/Sci/R&D Officer | 01/12/2021 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Chief Tech/Sci/R&D Officer | 01/03/2017 |
| Roche Corp. | Chief Tech/Sci/R&D Officer | 01/06/2012 |
| Université Claude Bernard Lyon 1 | Corporate Officer/Principal | - |
Formation de Raphaël Rousseau
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| GRITSTONE BIO, INC. | Health Technology |
| DAY ONE BIOPHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
| Université Paris Diderot-Paris 7 | Consumer Services |
| Roche Corp. | |
| Université de Paris 5 René Descartes | Consumer Services |
